Waddell & Associates, LLC Gilead Sciences, Inc. Transaction History

Waddell & Associates, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$59.54 - $68.01 $45,309 - $51,755	-761 Reduced 16.15%	3,952 $244,000
Q2 2022 Jul 27, 2022	BUY	$57.72 - $65.01 $43,636 - $49,147	756 Added 19.11%	4,713 $291,000
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $5,514 - $6,259	85 Added 2.2%	3,957 $287,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $245,755 - $268,523	3,872 New	3,872 $267,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Waddell & Associates, LLC with notifications on news.